Meyka Pro banner
Cabot Corp.

Cabot Corp. (NYSE: CBT) Stock Competitors & Peer Comparison

See CBT's competitors and their performance on the NYSE and across the wider stock market.

CBTNYSE
Basic MaterialsChemicals - Specialty
$86.30
$0.68(0.78%)
U.S. Market opens in 15h 36m

Peer Comparison Table: Chemicals - Specialty Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for CBT and its NYSE peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CBT$87.62+0.08%4.5B13.45$6.51+2.09%
LIN$489.98-0.03%226.7B29.11$16.83+1.27%
SHW$369.73+1.74%89.7B32.01$11.55+0.86%
ECL$285.17+0.60%80.2B36.83$7.74+1.00%
APD$303.44+1.17%67.6B23.63$12.84+2.38%
PPG$119.72+2.19%26.6B15.56$7.69+2.37%
IFF$85.89+1.58%21.9B21.90$3.92+1.88%
SQM$71.95-0.69%20.6B25.23$2.86+1.42%
LYB$59.59-3.01%19.2B32.04$1.86+6.84%
ALB$131.11+4.54%15.5B21.93$5.98+1.25%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Linde plc (NASDAQ: LIN)

CBT vs LIN Comparison August 2026

Cabot Corp. (NYSE: CBT) plays a significant role within the Basic Materials sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CBT stands at 4.5B. In comparison, LIN has a market cap of 226.7B. Regarding current trading prices, CBT is priced at $87.62 on the NYSE, while LIN trades at $489.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CBT currently has a P/E ratio of 13.45, whereas LIN's P/E ratio is 29.11. In terms of profitability, CBT's ROE is +0.12%, compared to LIN's ROE of +0.19%. Regarding short-term risk, CBT is more volatile compared to LIN. This indicates higher risk in terms of short-term price fluctuations for CBT.Check LIN's competition here

Stock price comparison of stocks in the Basic Materials Sector

Loading...

Frequently Asked Questions